Validation of pikfyve inhibition as a therapeutic approach for diverse forms of frontotemporal dementia
Ended Project Grant Awarded Last action
- Award ID
- W81XWH2110168
- Recipient
-
University Of Southern California UEI G88KLJR3KYT5
- Awarding agency
-
Medical Command
Department of the Army, Department of Defense
- Obligated
- $330,000
Award facts
- Assistance listing
- 12.420 Military Medical Research and Development
- Completion date
- Place of performance
- Los Angeles, CA 90001, USA
Award details come from USAspending.gov.
About this award
The University of Southern California will receive $330,000 under a two-year Project Grant award from the Department of the Army Medical Command. The grant falls under the Military Medical Research and Development program (CFDA 12.420), which supports basic, applied, and advanced biomedical research to improve military and public health care.
Through this funding, USC will validate PIKFYVE inhibition as a therapeutic approach for diverse forms of frontotemporal dementia from March 2021 to March 2023. The university's research is expected to investigate medical solutions for neurological conditions affecting service members and civilians alike. By exploring this potential treatment pathway, the award seeks to transform healthcare and investigate options for conditions on the battlefield.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Amendment | $0 | |
| Original award | $330,000 |
Quick answers
Who received award W81XWH2110168?
W81XWH2110168 was awarded to University Of Southern California by Medical Command (Department of the Army) on March 15, 2021.
How much is award W81XWH2110168 worth?
$330,000 has been obligated on W81XWH2110168.
On GovTribe
See this award's full record
- Every transaction and subaward
- The recipient's other awards and teaming partners
- Similar grant awards
- Ask GovTribe AI about this award